Mylotarg and acute myeloid leukaemia 
Mylotarg and acute myeloid leukaemia Patient Reports February 12, 2012
Mylotarg Side Effects Report #5102975-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Female patient, 84 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, confusional state, malignant neoplasm progression, neutrophil count decreased, sepsis
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, PROTECADIN, MUCOSTA, VIT K CAP, SULFAMETHOXAZOLE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5084004-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, pneumonia
, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, URSO, OMEPRAZOLE, SULFAMETHOXAZOLE, DIFLUCAN, STRONG NEO MINOPHAGEN C. Patient died.Mylotarg Side Effects Report #5206008-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: 9 MG/M2 1X PER 1 DAY; INTRAVENOUS DRIP. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4929638-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2006. Female patient, 73 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, febrile neutropenia, hepatic enzyme increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient died on 09/05/2005.
Mylotarg Side Effects Report #5201931-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, gastroenteritis staphylococcal, malaise, neutrophil count decreased, platelet count decreased, pneumonia
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUPOGEN, ITRACONAZOLE, ALLOPURINOL, DIOVAN, INSULIN, EXACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5206754-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, enteritis, febrile neutropenia, gastrointestinal haemorrhage, hypokalaemia, hyponatraemia, liver disorder, lymphocyte percentage increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with RABEPRAZOLE, ISALON, VFEND, PANTOSIN, MAGNESIUM OXIDE, NEOPHAGEN, NEUPOGEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5110505-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, malignant neoplasm progression, pneumonia
, pyrexia, thrombocytopenia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE, NEORAL, TENORMIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4943875-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood calcium decreased, blood creatinine increased, blood potassium decreased, blood urea increased, haemorrhagic diathesis, malignant neoplasm progression, neutrophil percentage decreased, platelet count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA. Patient died.
Mylotarg Side Effects Report #4942761-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, diarrhoea, haemoglobin decreased, herpes zoster, hypokalaemia, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM. Patient died.
Mylotarg Side Effects Report #4991409-6
Mylotarg side effect was reported by a Physician from JAPAN on Apr 25, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood pressure decreased, depressed level of consciousness, diarrhoea. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM, MAXIPIME. Patient died.Mylotarg Side Effects Report #5076380-3
Mylotarg side effect was reported by a Health Professional from JAPAN on July 25, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow failure, cancer pain, cardiac failure congestive, constipation
, disseminated intravascular coagulation, febrile neutropenia, histiocytosis haematophagic, hypertension. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL, SUCRALFATE, LANSOPRAZOLE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5104155-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 31, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, coagulopathy, hyperbilirubinaemia, hyperglycaemia, hypochloraemia, hypokalaemia, hyponatraemia, hypotension. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FUNGUARD, SULFAMETHOXAZOLE, LOXONIN, MUCOSTA, ROCEPHIN, SAXIZON, NEUPOGEN, LASIX. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5121147-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 22, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, blood urea increased, bone marrow failure, cancer pain, cardiac failure congestive, chills, constipation
, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL, SUCRALFATE, LANSOPRAZOLE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5202114-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5158276-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4914259-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 07, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, cellulitis
, chills, disease progression, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient died.Mylotarg Side Effects Report #4979710-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 06, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, cellulitis
, chills, malignant neoplasm progression, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.Mylotarg Side Effects Report #5113914-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood bilirubin increased, disease progression, hepatomegaly, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, HYDREA, CIPROXAN, SULPERAZON, TOBRAMYCIN SULPHATE, FUNGUARD, VFEND, ZOVIRAX. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5196095-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2006. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, disease recurrence, lung injury, malignant neoplasm progression, mouth haemorrhage, platelet count decreased, po2 decreased, pseudomonal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, HYDREA, SULPERAZON, TOBRAMYCIN SULPHATE, FUNGUARD, ZOVIRAX, URSO. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4917046-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood stem cell transplant failure, bone marrow failure, c-reactive protein increased, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4974412-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 29, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent, bone marrow conditioning regimen and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, fibrin degradation products increased, hyperkalaemia, hyponatraemia, interstitial lung disease, malignant neoplasm progression, proctalgia, venoocclusive liver disease. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, BUSULFAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4953986-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage increased. Mylotarg dosage: A SINGLE 9 MG/M2 DOSE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4995945-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, malignant neoplasm progression, monocyte percentage decreased, neutrophil percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #5238582-2
Mylotarg side effect was reported by a Physician from JAPAN on Feb 09, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, bacterial infection
, fungal infection , prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , acute myeloid leukaemia, anorexia, dehydration, disease progression, fibrin degradation products increased, hepatitis , hiccups, immunosuppression. Mylotarg dosage: 16 MG (9 MG/M2/DAY). During the same period patient was treated with AMIKACIN SULPHATE, FUNGUARD, TIENAM, BAKTAR, ITRACONAZOLE. Patient recovered.Mylotarg Side Effects Report #5376161-7
Mylotarg side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5420780-6
Mylotarg side effect was reported by a Physician from JAPAN on Aug 17, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5481191-0
Mylotarg side effect was reported by a Physician from JAPAN on Sept 28, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, blood uric acid decreased, c-reactive protein increased, condition aggravated, febrile neutropenia, gastrointestinal haemorrhage, haematemesis. Mylotarg dosage: unknown. During the same period patient was treated with ITRIZOLE, MAXIPIME, IDAMYCIN, NOVANTRONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5511142-1
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood pressure diastolic increased, disease progression, gamma-glutamyltransferase increased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAZOLE, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5583086-0
Mylotarg side effect was reported by a Physician from JAPAN on Dec 26, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, c-reactive protein increased, fungaemia, hepatic function abnormal, infusion related reaction, malignant neoplasm progression, neutropenia, platelet count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, GASTER. Patient recovered.Mylotarg Side Effects Report #5765767-9
Mylotarg side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, constipation
, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, decreased appetite, fungaemia, neutrophil count decreased, platelet count decreased, pyrexia, sepsis , white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE HEAVY, OMEPRAL, PANTOSIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIFLUCAN. Patient recovered.Mylotarg Side Effects Report #4973907-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2006. Male patient, 87 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Mylotarg dosage: A SINGLE 13.3 MG DOSE, INTRAVENOUS. Patient died on 03/26/2006.
Mylotarg Side Effects Report #4986568-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 87 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression. Mylotarg dosage: A SINGLE 13.3 MG DOSE, INTRAVENOUS. Patient died on 03/26/2006.
Mylotarg Side Effects Report #4955671-8
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 10, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, febrile neutropenia, liver disorder, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, FOSMICIN S, MAXIPIME, VANCOMYCIN, FUNGUARD, PAZUCROSS. Patient recovered.
Mylotarg Side Effects Report #5007450-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, disease progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CIPROFLOXACIN, FOSMICIN S, FOSMICIN S, FUNGUARD, MAXIPIME. Patient recovered.Mylotarg Side Effects Report #5069585-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, epistaxis, hiccups, malignant neoplasm progression, platelet count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, DIFLUCAN, ROHYPNOL, LENDORM, DEPAS, CIPROXAN. Patient recovered.
Mylotarg Side Effects Report #5097834-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Male patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, anaemia, cardio-respiratory arrest, coagulopathy, disease progression, epistaxis, haemoptysis, hiatus hernia. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 06/11/2005.
Mylotarg Side Effects Report #4867664-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 1999. Female patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, nausea
, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M (2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/22/1998.Mylotarg Side Effects Report #5032140-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Male patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardio-respiratory arrest, disease progression, epistaxis, haemoptysis, hypotension, melaena, myelodysplastic syndrome, respiratory distress. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 06/11/2005.
Mylotarg Side Effects Report #5113917-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, disease progression, myeloblast count increased, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE. Patient recovered.
Mylotarg Side Effects Report #4952638-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2004. Male patient, 79 years of age, weighting 187.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacteria blood identified, chills, febrile neutropenia, infusion related reaction, malignant neoplasm progression, pneumonia
, pyrexia, white blood cell count abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with HYDREA, SYNTHROID, PREVACID, ALLOPURINOL. Patient was hospitalized. Patient died on 01/22/2003.Mylotarg Side Effects Report #5042462-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, malignant neoplasm progression, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE, FIRSTCIN, CEFPIRAMIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5093595-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood calcium decreased, blood potassium decreased, blood urea increased, disease progression, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.
Mylotarg Side Effects Report #5134042-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, disease progression, eating disorder
, febrile neutropenia, hyperuricaemia, hypoproteinaemia, infection , infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FOSMICIN S, MAXIPIME, NIZATIDINE, SUCRALFATE, LASIX, DAUNORUBICIN HYDROCHLORIDE, ENOCITAMINE. Patient recovered.Mylotarg Side Effects Report #5199525-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, eating disorder
, febrile neutropenia, hyperuricaemia, hypoproteinaemia, infection , infusion related reaction, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FOSMICIN S, MAXIPIME, NIZATIDINE, SUCRALFATE, LASIX, DAUNORUBICIN HYDROCHLORIDE, ENOCITABINE. Patient recovered.Mylotarg Side Effects Report #4951697-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood potassium decreased, blood urea increased, blood uric acid increased, decreased appetite, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.
Mylotarg Side Effects Report #5025982-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 30, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN. Patient recovered.
Mylotarg Side Effects Report #4893551-7
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 12, 2006. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood pressure diastolic decreased, body temperature decreased, contusion, disease progression, fall
, head injury, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, BEPRIDIL HYDROCHLORIDE MONOHYDRATE, DIOVAN. Patient died.Mylotarg Side Effects Report #4943877-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood pressure diastolic decreased, body temperature decreased, fall
, haematocrit decreased, haemoglobin decreased, head injury, malignant neoplasm progression, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, BEPRIDIL HYDROCHLORIDE MONOHYDRATE, DIOVAN. Patient died.Mylotarg Side Effects Report #4899279-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood potassium decreased, febrile neutropenia, hypoxia, malignant neoplasm progression, ventricular tachycardia. Mylotarg dosage: 9 MG/M^2 1X PER DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, CYTARABINE. Patient died.
Mylotarg Side Effects Report #4949974-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 74 years of age, weighting 168.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chills, disease progression, infection
, infusion related reaction, pyrexia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, METOPROLOL, ISOSORBIDE, DIPHENHYDRAMINE, ALLOPURINOL, NEXIUM, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/30/2002.Mylotarg Side Effects Report #4958840-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood potassium decreased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion, pulmonary oedema. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #4977027-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 74 years of age, weighting 168.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, infection
, infusion related reaction, nausea , pyrexia, white blood cell count decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, METOPROLOL, ISOSORBIDE, DIPHENHYDRAMINE, ALLOPURINOL, NEXIUM, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/30/2002.Mylotarg Side Effects Report #4998575-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood urea increased, body temperature increased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4867537-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2005. Female patient, 73 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, platelet count decreased. Mylotarg dosage: 1 SINGLE 9 MG DOSE, INTRAVENOUS; SEE IMAGE. Patient was hospitalized. Patient died on 09/05/2005.
Mylotarg Side Effects Report #4967137-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Male patient, 73 years of age, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, disease progression, hepatic failure, hepatomegaly, malaise, pleural effusion, renal failure acute, splenomegaly. Mylotarg dosage: 15.3 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, ATENOLOL, FUROSEMIDE, FLUCONAZOLE, LISINOPRIL, POTASSIUM CHLORIDE, NITROGLYCERIN TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4952733-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2004. Male patient, 72 years of age, weighting 321.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, shoulder pain, white blood cell count decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant
, chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5096605-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacterial sepsis, blood culture positive, disease progression, dyspnoea, febrile neutropenia, hypotension, myelodysplastic syndrome, staphylococcal infection
. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #4899281-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, blood urea increased, febrile neutropenia, fibrin degradation products increased, immunosuppression, interstitial lung disease, malignant neoplasm progression, pneumonia fungal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with OZEX, ITRACONAZOLE, SULFAMETHOXAZOLE, URSO, ACTOS. Patient died.
Mylotarg Side Effects Report #4986553-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, chills, disease progression, dizziness
, dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #4867658-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Female patient, 69 years of age, weighting 145.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, atrial fibrillation
, febrile neutropenia, furuncle, hypotension, malignant neoplasm progression, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, DIGOXIN, OMEPRAZOLE, ALLOPURINOL. Patient was hospitalized. Patient died on 11/11/1999.Mylotarg Side Effects Report #5032005-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5101928-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal tenderness, acute myeloid leukaemia, acute respiratory distress syndrome, anti-hbs antibody positive, atrial fibrillation
, chills, confusional state, diarrhoea, enterococcal sepsis. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN, ALLOPURINOL, CETIRIZINE, FLUTICASONE PROPIONATE, SULFADIAZINE SILVER, QUINAPRIL, PANTOPRAZOLE. Patient was hospitalized. Patient died on 06/10/2003.Mylotarg Side Effects Report #5134994-6
Mylotarg side effect was reported by a Physician from UNITED STATES on Oct 12, 2006. Male patient, 68 years of age, weighting 173.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, bundle branch block left, diarrhoea, diastolic dysfunction, dysgeusia, erosive oesophagitis, febrile neutropenia, gastric polyps. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PRIMAXIN, VALTREX, LEVAQUIN, ACETAMINOPHEN, FUROSEMIDE, FAMOTIDINE, VORICONAZOLE, CYTARABINE. Patient was hospitalized. Patient died on 04/11/2003.
Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #4942641-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cellulitis
, malignant neoplasm progression. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 12/17/2005.Mylotarg Side Effects Report #5097836-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Female patient, 66 years of age, weighting 106.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, culture urine positive, dyspnoea, enterococcal infection, haemoptysis, hydropneumothorax, leukaemia cutis, malignant neoplasm progression. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 12/03/2003.
Mylotarg Side Effects Report #5128900-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPRO, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5142837-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 66 years of age, weighting 106.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, culture urine positive, enterococcal infection, haemoptysis, hydropneumothorax, leukaemia cutis, malignant neoplasm progression, pharyngolaryngeal pain. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 12/03/2003.
Mylotarg Side Effects Report #4949624-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5106489-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, dizziness
, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.Mylotarg Side Effects Report #4953648-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 64 years of age, weighting 164.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chills, dyspnoea, hypotension, infusion related reaction, malignant neoplasm progression, oxygen saturation decreased, pyrexia, tachycardia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, DIPHENHYDRAMINE, PERCOCET, RESTORIL, ATIVAN. Patient died on 07/31/2003.
Mylotarg Side Effects Report #5042480-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, histiocytosis haematophagic, malignant neoplasm progression, pulmonary haemorrhage. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4709010-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2004. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, asthenia, fatigue, malignant neoplasm progression, multi-organ failure, pain
, pleural effusion, pyrexia. Mylotarg dosage: 2 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE, MDIAZOLAM, FENTANYL, HYDROCORTISONE NA SUCCINATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 09/17/2002.Mylotarg Side Effects Report #4863969-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE. Patient died.
Mylotarg Side Effects Report #4869686-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M 2 1X PER 1 DAY. Patient died.
Mylotarg Side Effects Report #5007452-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection
, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with LEVOFLOXACIN, DIFLUCAN. Patient recovered.Mylotarg Side Effects Report #5008804-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 11, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE, OMEGACIN. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4867706-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 09, 1999. Male patient, 61 years of age, weighting 179.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, lung infiltration, malignant neoplasm progression, mental status changes, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/08/1999.
Mylotarg Side Effects Report #4914311-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2002. Male patient, 61 years of age, weighting 179.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, lung infiltration, malignant neoplasm progression, mental status changes, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/08/1999.
Mylotarg Side Effects Report #5053180-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Male patient, 60 years of age, weighting 261.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacteria stool identified, diarrhoea, febrile neutropenia, haemoglobin decreased, hyponatraemia, malignant neoplasm progression, nausea
, renal failure. Mylotarg dosage: INTRAVENOUS, 18MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with PROTONIX, ZOLOFT, COMBIVENT, COREG, NEURONTIN, LEVAQUIN, LASIX. Patient was hospitalized. Patient died on 03/05/2004.Mylotarg Side Effects Report #4948798-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 287.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood pressure increased, dialysis
, disease progression, hepatic steatosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with INSULIN, ACYCLOVIR, ALLOPURINOL, NORVASC, FIBRALAX, CIPROFLOXACIN, KLONOPIN. Patient was hospitalized. Patient died on 11/01/2003.Mylotarg Side Effects Report #5191249-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia, bacterial infection
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, dehydration, fibrin degradation products increased, hepatitis , hiccups, immunosuppression, interstitial lung disease, malignant neoplasm progression. Mylotarg dosage: 16 MG (9 MG/M2/DAY) INTRAVENOUS DRIP. During the same period patient was treated with VFEND, MEROPEN, AMIKACIN SULPHATE, FUNGUARD, TIENAM, OZEX, SULFAMETHOXAZOLE, ITRACONAZOLE. Patient recovered.Mylotarg Side Effects Report #4685924-2
Mylotarg side effect was reported by a Physician from on May 25, 2005. Female patient, 59 years of age, weighting 101.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, pancytopenia, streptococcal infection
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ASPIRIN, LANOXIN, ENALAPRIL MALEATE, ACYCLOVIR, PROZAC, DEMECLOCYCLINE, DIFLUCAN. Patient was hospitalized. Patient died on 04/22/2003.Mylotarg Side Effects Report #4744989-X
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 03, 2005. Male patient, 58 years of age, weighting 212.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, beta haemolytic streptococcal infection, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, malignant neoplasm progression, oedema peripheral, sepsis
. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AVANDIA, SPORANOX, CIPRO, KEFLEX, VALCYTE, FOLIC ACID, DIGOXIN. Patient was hospitalized. Patient died on 09/07/2003.Mylotarg Side Effects Report #4967481-6
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, bacteria urine identified, blood culture positive, chills, clostridium colitis, cough, effusion, febrile neutropenia. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 11/08/2005.
Mylotarg Side Effects Report #5119352-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 57 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac failure congestive, disease progression, dysuria, febrile neutropenia, infusion related reaction, myalgia, obstruction gastric, pancreatitis acute. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, ALLOPURINOL, AMBIEN, PREVACID, PHYTONADIONE, CELEBREX. Patient was hospitalized. Patient died on 09/07/2002.
Mylotarg Side Effects Report #5191248-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cells present, blood bilirubin increased, blood creatinine increased, blood urea increased, c-reactive protein increased, haematocrit decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with PRODIF, FIRSTCIN, OMEPRAL, STRONG NEO MINOPHAGEN C. Patient recovered.
Mylotarg Side Effects Report #4952754-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 29, 2004. Male patient, 57 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, bile duct obstruction, bone marrow leukaemic cell infiltration, cardiac failure congestive, diarrhoea, disease progression, dysuria, febrile neutropenia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, ALLOPURINOL, AMBIEN, PREVACID, VITAMIN K, CELEBREX. Patient was hospitalized. Patient died on 09/07/2002.
Mylotarg Side Effects Report #5053178-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient, 55 years of age, weighting 194.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, malignant neoplasm progression, weight increased. Mylotarg dosage: 14.85 MG 1X PER 1 DAY; INTRAVENOUS. Patient died on 01/07/2006.
Mylotarg Side Effects Report #4952736-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2004. Male patient, 55 years of age, weighting 301.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, bacterial sepsis, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, blood lactate dehydrogenase increased, bone marrow failure, cholelithiasis. Mylotarg dosage: 22.5 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 05/04/2003.
Mylotarg Side Effects Report #4952711-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 51 years of age, weighting 205.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, asterixis, bacteria urine identified, confusional state, haemodialysis, hepatic failure, hypotension, hypoxia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNOMYCIN. Patient was hospitalized. Patient died on 09/15/2005.
Mylotarg Side Effects Report #4706901-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2004. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, arthralgia, aspartate aminotransferase increased, asthenia, blood bilirubin increased, blood pressure increased, blood urea increased, haematocrit decreased. Mylotarg dosage: 4 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with MEDROXYPROGESTERONE ACETTE, ZOLPIDEM TARTRATE, ALLOPURINOL, ACYCLOVIR, CYCLOSPORINE, VITAMINS, ITRACONAZOLE. Patient was hospitalized. Patient died on 06/26/2000.
Mylotarg Side Effects Report #4785598-6
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 20, 2005. Female patient, 50 years of age, weighting 168.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute myeloid leukaemia recurrent, aspergillosis, febrile neutropenia, gastrointestinal haemorrhage, graft versus host disease, pain
, pancytopenia, pleural effusion. Mylotarg dosage: 7.3 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUCONAZOLE, ACYCLOVIR, PREDNISONE, KLONOPIN, CALCIUM WITH VITAMIN D. Patient was hospitalized and became disabled. Patient died on 11/10/2001.Mylotarg Side Effects Report #4801592-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2005. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory failure, arthralgia, aspartate aminotransferase increased, asthenia, blood bilirubin increased, blood calcium increased, blood magnesium increased, blood pressure increased. Mylotarg dosage: 4 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with MEDROXYPROGESTERONE, ZOLPIDEM TARTRATE, ALLOPURINOL, ACYCLOVIR, CYCLOSPORINE, VITAMINS, ITRACONAZOLE. Patient was hospitalized. Patient died on 06/26/2000.
Mylotarg Side Effects Report #5079822-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 49 years of age, weighting 123.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, sepsis
. Mylotarg dosage: 9 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 05/09/2002.Mylotarg Side Effects Report #5141862-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 20, 2006. Male patient, 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, hypercoagulation, hypoalbuminaemia, hypokalaemia, hypoproteinaemia, malignant neoplasm progression, neutropenia, pneumonia
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with FIRSTCIN, FUTHAN, DIFLUCAN, TIENAM, AMIKACIN SULPHATE. Patient died.Mylotarg Side Effects Report #4971950-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, fibrin degradation products increased, fungal infection
, haemoglobin decreased, immunodeficiency, malignant neoplasm progression, platelet count decreased, sepsis , weight increased. Mylotarg dosage: unknown. During the same period patient was treated with POLYMYXIN B SULPHATE, DIFLUCAN, SULFAMETHOXAZOLE, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5023797-9
Mylotarg side effect was reported by a Health Professional from JAPAN on May 22, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blast cell count increased, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, fibrin degradation products increased, fungal infection
, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, DIFLUCAN, SULFAMETHOXAZOLE, MUCOSTA. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5013787-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 37 years of age, weighting 271.8 lb, was diagnosed with acute myeloid leukaemia, fungal infection
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, renal failure, white blood cell count decreased. Mylotarg dosage: 9 MG/M^1 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPHOTERICIN B, DEMEROL, AMILORIDE, ASCORBIC ACID, VITAMINS, NEURONTIN, BENADRYL. Patient was hospitalized. Patient died on 01/29/2003.